Immunostaining of PD-1/PD-Ls in liver tissues of patients with hepatitis and hepatocellular carcinoma

doi:10.3748/wjg.v17.i28.3322

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 28

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7415)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-6) series.

Item

Count

PDF

731

HTML

6356

Figures (1-3)

166

Tables (1-6)

162

Sum=7415

Jul 28, 2011 (publication date) through Jul 6, 2024

Times Cited of This Article

Times Cited (115)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Jul 28, 2011; 17(28): 3322-3329
Published online Jul 28, 2011. doi: 10.3748/wjg.v17.i28.3322

Table 6 Comparison of programmed death 1/programmed death-L expression in liver tissues of patients with hepatitis or hepatocellular carcinoma (mean ± SD)

Diagnosis	n	PD-1	P	PD-L1	P	PD-L2	P
Hepatitis	20	1.40 ± 1.536	0.000	1.05 ± 1.099	0.004	1.80 ± 1.473	0.020
HCC	26	5.71 ± 4.051		4.29 ± 3.885		3.81 ± 3.400

PD: Programmed death; PD-L: Programmed death ligand; HCC: Hepatocellular carcinoma.

Citation: Wang BJ, Bao JJ, Wang JZ, Wang Y, Jiang M, Xing MY, Zhang WG, Qi JY, Roggendorf M, Lu MJ, Yang DL. Immunostaining of PD-1/PD-Ls in liver tissues of patients with hepatitis and hepatocellular carcinoma. World J Gastroenterol 2011; 17(28): 3322-3329
URL: https://www.wjgnet.com/1007-9327/full/v17/i28/3322.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i28.3322